持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/04/07 | 日証協 | 159,661株 | +184.29% | 156,277株 | +127.96% | 223,923株 | +26% | 151,892株 | -14.21% |
2023/03/31 | 日証協 | 56,161株 | -61.07% | 68,555株 | -32.13% | 177,710株 | -26.01% | 177,045株 | +8.25% |
2023/03/24 | 日証協 | 144,249株 | -5.37% | 101,016株 | -52.96% | 240,172株 | +38.68% | 163,551株 | +51.32% |
2023/03/17 | 日証協 | 152,429株 | +21.25% | 214,723株 | +26.54% | 173,189株 | +30.67% | 108,081株 | +337.22% |
2023/03/10 | 日証協 | 125,719株 | +1.73% | 169,682株 | +51.53% | 132,538株 | +7.3% | 24,720株 | +10.75% |
2023/03/03 | 日証協 | 123,577株 | +10.94% | 111,979株 | -2.02% | 123,517株 | +3.16% | 22,320株 | -20.06% |
2023/02/24 | 日証協 | 111,390株 | +42.83% | 114,286株 | +172.53% | 119,730株 | +6.87% | 27,920株 | +24.25% |
2023/02/17 | 日証協 | 77,990株 | -30.79% | 41,935株 | +3.34% | 112,030株 | -23.43% | 22,470株 | +36.38% |
2023/02/10 | 日証協 | 112,690株 | -18.67% | 40,580株 | -58.16% | 146,318株 | -9.13% | 16,476株 | -74.53% |
2023/02/03 | 日証協 | 138,553株 | -9.12% | 96,994株 | +250.01% | 161,011株 | -7.15% | 64,688株 | +103.98% |
2023/01/27 | 日証協 | 152,453株 | -12.92% | 27,712株 | -36.29% | 173,404株 | -5.77% | 31,713株 | -20.99% |
2023/01/20 | 日証協 | 175,080株 | +17.48% | 43,500株 | -12.06% | 184,031株 | +1.38% | 40,140株 | -10.31% |
2023/01/13 | 日証協 | 149,026株 | +9.31% | 49,464株 | +588.15% | 181,531株 | +6.19% | 44,753株 | +9.52% |
2023/01/06 | 日証協 | 136,335株 | -2.23% | 7,188株 | +12.74% | 170,942株 | +0.06% | 40,864株 | +34.72% |
2022/12/30 | 日証協 | 139,450株 | -7.16% | 6,376株 | -85.46% | 170,842株 | -2.15% | 30,332株 | -59.71% |
2022/12/23 | 日証協 | 150,208株 | +8.35% | 43,861株 | -65.92% | 174,590株 | +9.17% | 75,276株 | +47.02% |
2022/12/16 | 日証協 | 138,626株 | +1.34% | 128,700株 | +131.58% | 159,926株 | +6.52% | 51,200株 | +1.97% |
2022/12/09 | 日証協 | 136,790株 | -8% | 55,574株 | -58.47% | 150,139株 | -0.13% | 50,212株 | -0.57% |
2022/12/02 | 日証協 | 148,678株 | +6.9% | 133,810株 | +1721.54% | 150,327株 | +12.41% | 50,500株 | +139.92% |
※株式分割は考慮していませんのでご注意ください。
Page Top